Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Dite

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian womenA B Spurdle, J L Hopper, X Chen, et al.
Journal of the National Cancer Institute|October 19, 2000
CYP17 promoter polymorphism and breast cancer in Australian women under age forty yearsA B Spurdle, J L Hopper, G S Dite, et al.
Cancer Research|April 23, 1999
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based studyJ E Armes, L Trute, D White, et al.
British Journal of Cancer|February 20, 2014
Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family RegistryM E Work, E M John, I L Andrulis, et al.
British Journal of Cancer|August 15, 2013
Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentreR J MacInnis, A Bickerstaffe, C Apicella, et al.
Journal of the National Cancer Institute|June 8, 1999
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty yearsA B Spurdle, G S Dite, X Chen, et al.
British Journal of Cancer|February 24, 2011
Morphological predictors of BRCA1 germline mutations in young women with breast cancerM C Southey, S J Ramus, J G Dowty, et al.
British Journal of Cancer|September 30, 2010
Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutationsG S Dite, A S Whittemore, J A Knight, et al.
British Journal of Cancer|July 17, 1999
BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancerM C Southey, A A Tesoriero, C R Andersen, et al.
Clinical Genetics|July 31, 2007
Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish womenC Apicella, J G Dowty, G S Dite, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian womenA B Spurdle, J L Hopper, X Chen, et al.
Journal of the National Cancer Institute|October 19, 2000
CYP17 promoter polymorphism and breast cancer in Australian women under age forty yearsA B Spurdle, J L Hopper, G S Dite, et al.
Cancer Research|April 23, 1999
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based studyJ E Armes, L Trute, D White, et al.
British Journal of Cancer|February 20, 2014
Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family RegistryM E Work, E M John, I L Andrulis, et al.
British Journal of Cancer|August 15, 2013
Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentreR J MacInnis, A Bickerstaffe, C Apicella, et al.
Journal of the National Cancer Institute|June 8, 1999
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty yearsA B Spurdle, G S Dite, X Chen, et al.
British Journal of Cancer|February 24, 2011
Morphological predictors of BRCA1 germline mutations in young women with breast cancerM C Southey, S J Ramus, J G Dowty, et al.
British Journal of Cancer|September 30, 2010
Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutationsG S Dite, A S Whittemore, J A Knight, et al.
British Journal of Cancer|July 17, 1999
BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancerM C Southey, A A Tesoriero, C R Andersen, et al.
Clinical Genetics|July 31, 2007
Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish womenC Apicella, J G Dowty, G S Dite, et al.
Pageof 3